Oncology
Eli Lilly Drug Significantly Reduces the Risk of Breast Cancer Returning
Eli Lilly and Company
PR-M06-20-NI-020Jun 16, 2020
Prevention
Could Preventing the Development of Amyloid Beta Lesions in the Brain Stop Alzheimer’s?
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M09-19-NI-012Sep 11, 2019
Vaccine
Pfizer Announces Positive Preliminary Results from a 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for Disease Prevention in Infants
Pfizer
PR-M09-19-NI-028Sep 11, 2019
Gene Therapy
Could a Gene Therapy Prevent Sudden Cardiac Death?
Emilie Branch
Pharma's Almanac
PAO-M08-19-NI-012Aug 07, 2019
Migraine Prevention
Eli Lilly Looking to Boost Sales of Migraine Med with New Data on Emergency Room Visits
Pharma's Almanac
PAO-M08-19-NI-004Aug 01, 2019
HIV Prevention
Descovy Shown to be As Effective and Safer than Truvada as a Preventive HIV Treatment
Pharma's Almanac
PAO-M04-19-NI-011Apr 10, 2019
FDA
Lilly Receives FDA Priority Review Designation for Emgality® (galcanezumab-gnlm) Injection for the Preventive Treatment of Episodic Cluster Headache in Adults
Eli Lilly and Company
PR-M03-19-NI-017Mar 07, 2019
FDA
Statement from FDA Commissioner Scott Gottlieb, M.D., on Proposed New Steps to Protect Youth by Preventing Access to Flavored Tobacco Products
U.S. Food & Drug Administration
PR-M11-18-NI-058Nov 16, 2018